Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein
ACS Chemical Biology · 2024-02-16 · 19 (2) · 451-461
DOI: 10.1021/acschembio.3c00640 ↗At a glance
Fallbericht in ACS Chemical Biology, published online on 2024-02-06. Written by Jana Volarić and 7 co-authors. Institution: Stratingh Institute for Organic Chemistry, University of Groningen, 9747 AG Groningen, The Netherlands. Major MEDLINE topics: Light, Azo Compounds. Cited 15 times so far (Crossref); 99 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Research Council, Ministerie van Onderwijs, Cultuur en Wetenschap, KWF Kankerbestrijding.
Abstract (original language)
Enabling control over the bioactivity of proteins with light, along with the principles of photopharmacology, has the potential to generate safe and targeted medical treatments. Installing light sensitivity in a protein can be achieved through its covalent modification with a molecular photoswitch. The general challenge in this approach is the need for the use of low energy visible light for the regulation of bioactivity. In this study, we report visible light control over the cytolytic activity of a protein. A water-soluble visible-light-operated tetra-ortho-fluoro-azobenzene photoswitch was synthesized by utilizing the nucleophilic aromatic substitution reaction for installing a solubilizing sulfonate group onto the electron-poor photoswitch structure. The azobenzene was attached to two cysteine mutants of the pore-forming protein fragaceatoxin C (FraC), and their respective activities were evaluated on red blood cells. For both mutants, the green-light-irradiated sample, containing predominantly the cis-azobenzene isomer, was more active compared to the blue-light-irradiated sample. Ultimately, the same modulation of the cytolytic activity pattern was observed toward a hypopharyngeal squamous cell carcinoma. These results constitute the first case of using low energy visible light to control the biological activity of a toxic protein.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Stratingh Institute for Organic Chemistry, University of Groningen, 9747 AG Groningen, The Netherlands.
- Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG Groningen, The Netherlands.
- Department of Surgery, Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
- Department of Radiology, Medical Imaging Center, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
ORCID profiles: Natalie L Mutter, Giovanni Maglia, Ben L Feringa
Funding
- European Research Council
- Ministerie van Onderwijs, Cultuur en Wetenschap
- KWF Kankerbestrijding
- H2020 European Research Council
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Cite
APA
Volarić, J., van der Heide, N. J., Mutter, N. L., Samplonius, D. F., Helfrich, W., Maglia, G., Szymanski, W., & Feringa, B. L. (2024). Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein. ACS Chemical Biology, 19(2), 451-461. https://doi.org/10.1021/acschembio.3c00640
Vancouver
Volarić J, van der Heide NJ, Mutter NL, Samplonius DF, Helfrich W, Maglia G, et al. Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein. ACS Chemical Biology. 2024;19(2):451-461. doi:10.1021/acschembio.3c00640
BibTeX
@article{Volari2024,
author = {Volarić, Jana and van der Heide, Nieck J and Mutter, Natalie L and Samplonius, Douwe F and Helfrich, Wijnand and Maglia, Giovanni and Szymanski, Wiktor and Feringa, Ben L},
title = {Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein},
journal = {ACS Chemical Biology},
year = {2024},
volume = {19},
number = {2},
pages = {451--461},
doi = {10.1021/acschembio.3c00640}
}
EUVIMED